anisodamine has been researched along with Hypertension, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, BM; Li, JX; Lu, CY; Oliver, JR; Philips, JB | 1 |
| Fan, YL; Hu, F; Sun, HL; Sun, YW; Wang, XQ; Xiao, YZ; Yang, L; Zhou, WQ | 1 |
2 other study(ies) available for anisodamine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Delayed thromboxane synthesis inhibition, but not cholinergic blockade, reverses group B streptococcus-induced pulmonary hypertension.
Topics: Animals; Blood Gas Analysis; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Pulmonary; Imidazoles; Parasympatholytics; Pulmonary Circulation; Solanaceous Alkaloids; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vasodilator Agents | 1992 |
[Effects of anisodamine and scopolamine on pulmonary circulation in rabbits].
Topics: Animals; Blood Pressure; Female; Femoral Artery; Hypertension, Pulmonary; Male; Pulmonary Artery; Pulmonary Circulation; Rabbits; Scopolamine; Solanaceous Alkaloids; Vascular Resistance | 1986 |